Chau‐Ting Yeh

10.3k total citations · 1 hit paper
292 papers, 8.0k citations indexed

About

Chau‐Ting Yeh is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Chau‐Ting Yeh has authored 292 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Epidemiology, 155 papers in Hepatology and 85 papers in Molecular Biology. Recurrent topics in Chau‐Ting Yeh's work include Hepatitis B Virus Studies (125 papers), Hepatitis C virus research (116 papers) and Liver Disease Diagnosis and Treatment (93 papers). Chau‐Ting Yeh is often cited by papers focused on Hepatitis B Virus Studies (125 papers), Hepatitis C virus research (116 papers) and Liver Disease Diagnosis and Treatment (93 papers). Chau‐Ting Yeh collaborates with scholars based in Taiwan, United States and United Kingdom. Chau‐Ting Yeh's co-authors include Yun‐Fan Liaw, Chia‐Ming Chu, Rong‐Nan Chien, Kwang‐Huei Lin, I‐Shyan Sheen, Sun‐Lung Tsai, J H Ou, Ming‐Wei Lai, Kung‐Hao Liang and Tse‐Ching Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Chau‐Ting Yeh

287 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B

2002 543 citations Rong‐Nan Chien, Chau‐Ting Yeh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chau‐Ting Yeh Taiwan	45	4.4k	4.1k	2.2k	1.3k	866	292	8.0k
Seung Kew Yoon South Korea	50	4.3k 1.0×	5.3k 1.3×	2.2k 1.0×	1.2k 0.9×	1.4k 1.6×	333	9.8k
Tatsuo Kanda Japan	43	3.4k 0.8×	3.4k 0.8×	1.8k 0.8×	702 0.5×	879 1.0×	359	7.3k
Ratna B. Ray United States	63	4.0k 0.9×	3.5k 0.9×	4.6k 2.1×	2.0k 1.5×	1.4k 1.6×	177	10.5k
Jing‐hsiung James Ou United States	44	4.3k 1.0×	2.6k 0.6×	2.9k 1.3×	475 0.4×	512 0.6×	100	7.6k
Curt H. Hagedorn United States	38	1.7k 0.4×	2.2k 0.5×	3.4k 1.5×	1.6k 1.2×	701 0.8×	90	7.3k
Junqi Niu China	40	2.9k 0.7×	2.5k 0.6×	1.5k 0.7×	560 0.4×	397 0.5×	267	5.7k
Hong Ren China	38	2.2k 0.5×	1.8k 0.4×	1.4k 0.6×	515 0.4×	512 0.6×	310	5.4k
Thomas Longerich Germany	45	1.9k 0.4×	1.7k 0.4×	3.3k 1.5×	1.8k 1.4×	1.4k 1.6×	205	7.4k
Hiroyuki Marusawa Japan	43	2.4k 0.6×	2.0k 0.5×	2.9k 1.3×	1.3k 1.0×	1.5k 1.7×	160	7.1k
Tatsuya Kanto Japan	46	2.5k 0.6×	2.6k 0.6×	1.9k 0.8×	702 0.5×	864 1.0×	218	6.9k

Countries citing papers authored by Chau‐Ting Yeh

Since Specialization

Citations

This map shows the geographic impact of Chau‐Ting Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chau‐Ting Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chau‐Ting Yeh more than expected).

Fields of papers citing papers by Chau‐Ting Yeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chau‐Ting Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chau‐Ting Yeh. The network helps show where Chau‐Ting Yeh may publish in the future.

Co-authorship network of co-authors of Chau‐Ting Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Chau‐Ting Yeh. A scholar is included among the top collaborators of Chau‐Ting Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chau‐Ting Yeh. Chau‐Ting Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chu, Yu‐De, et al.. (2024). Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms. Lab on a Chip. 24(15). 3668–3678. 4 indexed citations

Huang, Ya‐Hui & Chau‐Ting Yeh. (2023). Anticancer Effects of Antidepressants in Hepatocellular Carcinoma Cells. Anticancer Research. 43(3). 1201–1206. 6 indexed citations

Chu, Yu‐De, Li-Chun Cheng, Siew‐Na Lim, et al.. (2023). Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect. Cell Death and Disease. 14(10). 660–660. 34 indexed citations

Lin, Chih‐Lang, Szu‐Yuan Wu, Ming‐Wei Lai, et al.. (2023). Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy. Cancers. 15(13). 3343–3343. 2 indexed citations

Chu, Yu‐De, Tan‐Chi Fan, Ming‐Wei Lai, & Chau‐Ting Yeh. (2022). GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells. Cell Death and Disease. 13(11). 956–956. 27 indexed citations

Chen, Wei‐Ting, Shi‐Ming Lin, Wei‐Chen Lee, et al.. (2022). GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatology International. 16(1). 148–158. 11 indexed citations

Jang, Anna C.-C., Wei-Cheng Lin, Haiwei Pi, et al.. (2022). Drosophila CTP synthase regulates collective cell migration by controlling the polarized endocytic cycle. Development. 149(16).

Lai, Ming‐Wei, et al.. (2022). Absence of chronicity in infants born to immunized mothers with occult HBV infection in Taiwan. Journal of Hepatology. 77(1). 63–70. 5 indexed citations

Wang, Xiaohong, et al.. (2021). Liver-lobule-mimicking patterning via dielectrophoresis and hydrogel photopolymerization. Sensors and Actuators B Chemical. 343. 130159–130159. 18 indexed citations

10.

Liu, Yu‐Chin, Chia‐Jung Li, Nian‐Kang Sun, et al.. (2019). Hepatitis B Virus X Protein Induces RHAMM-Dependent Motility in Hepatocellular Carcinoma Cells via PI3K–Akt–Oct-1 Signaling. Molecular Cancer Research. 18(3). 375–389. 16 indexed citations

11.

Lin, Chih‐Lang, Chao‐Wei Hsu, Ming‐Ling Chang, et al.. (2019). Decreasing seroprevalence of anti‐hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019. Journal of Medical Virology. 92(1). 124–127. 3 indexed citations

12.

Shyu, Yu‐Chiau, Ting Huang, Cheng‐Hung Chien, et al.. (2019). Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population‐based cohort study. Journal of Viral Hepatitis. 26(6). 718–726. 28 indexed citations

13.

Liang, Kung‐Hao, Peng Zhang, Chih‐Lang Lin, et al.. (2019). Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients. Digestive Diseases and Sciences. 65(7). 2130–2139. 10 indexed citations

14.

Lai, Ming‐Wei, Chao‐Wei Hsu, Chih‐Lang Lin, et al.. (2018). Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study. Hepatology International. 12(5). 456–464. 12 indexed citations

15.

Huang, Ya‐Hui, Kwang‐Huei Lin, Jau‐Song Yu, et al.. (2018). Targeting HSP60 by subcutaneous injections of jetPEI/HSP60‐shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth. Molecular Carcinogenesis. 57(9). 1087–1101. 15 indexed citations

16.

Chen, Chih‐Cheng, Chi‐Yuan Chen, Shu‐Huei Wang, et al.. (2018). Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair. Cancers. 10(9). 320–320. 41 indexed citations

17.

Lin, Yang-Hsiang, Meng‐Han Wu, Ya‐Hui Huang, et al.. (2018). Thyroid hormone negatively regulates tumorigenesis through suppression of BC200. Endocrine Related Cancer. 25(12). 967–979. 20 indexed citations

18.

Hu, Jinghong, Mei‐Yen Chen, Chau‐Ting Yeh, et al.. (2016). Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients. Medicine. 95(18). e3546–e3546. 18 indexed citations

19.

Jiang, Shih Sheng, Shiu‐Feng Huang, Yng‐Tay Chen, et al.. (2014). Dysregulation of the TGFBI gene is involved in the oncogenic activity of the nonsense mutation of hepatitis B virus surface gene sW182*. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(7). 1080–1087. 5 indexed citations

20.

Chang, Li-Yuan, Yung‐Chang Lin, Jayashri Mahalingam, et al.. (2012). Tumor-Derived Chemokine CCL5 Enhances TGF-β–Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells. Cancer Research. 72(5). 1092–1102. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact